SBI Mutual Fund on Friday bought additional shares of pharmaceutical company Alkem Laboratories for Rs 300 crore through an open market transaction. According to the block deal data available on the National Stock Exchange, SBI Mutual Fund acquired 6.41 lakh shares or 0.54% stake in Mumbai-headquartered Alkem Laboratories.
The shares were picked up at an average price of Rs 4,680 apiece, taking the transaction value to Rs 300.32 crore.
After the stake buy, SBI Mutual Fund's holding in Alkem rose to 2.7% from 2.16%.
Meanwhile, Samprada & Nanhamati Singh Family Trust (related to Alkem promoters) offloaded the same number of shares of the company, showed the data on the NSE.
On Friday, shares of Alkem Laboratories fell 2.54% to close at Rs 4,600.05 apiece on the NSE.
RECOMMENDED FOR YOU
SBI General Insurance, SBI Mutual Fund Considered For Public Listing: Chairman C S Setty
Aug 09, 2025
JSW Cement Raises Rs 1,080 Crore From Anchor Investors Prior To IPO Launch
Aug 06, 2025
M&B Engineering Raises Rs 292 Crore From Anchor Investors Ahead Of IPO
Jul 29, 2025
SBI Cards Share Price Falls Over 6% After Q1 Profit Dips
Jul 28, 2025
POPULAR